Filing Details
- Accession Number:
- 0001567619-20-016247
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-01 17:31:50
- Reporting Period:
- 2020-09-01
- Accepted Time:
- 2020-09-01 17:31:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1724344 | Entasis Therapeutics Holdings Inc. | ETTX | Pharmaceutical Preparations (2834) | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1080014 | Innoviva, Inc. | 1350 Old Bayshore Highway Suite 400 Burlingame CA 94010 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-01 | 4,672,897 | $2.68 | 18,672,897 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants to Purchase Common Stock | Acquisiton | 2020-09-01 | 4,672,897 | $2.68 | 4,672,897 | $2.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,672,897 | 2020-09-01 | 2025-09-01 | No | 4 | P | Direct |
Footnotes
- See Exhibit 99.1
Billionaire Hedge Funds
